P L
Experienced Analytical Scientist with 10+ years in biologics and gene therapy
Hire this person
Send a job offer directly to this candidate
About
Experienced Analytical Scientist with 10+ years in biologics and gene therapy, specializing in method development, qualification, and technology transfer. Proven expertise in Mass Photometry, AUC, SEC-MALS, DLS, CE-SDS, IEX, SDS-PAGE, and PCR. Demonstrated success in QC testing, GLP-compliant assay development, and presenting complex data to cross-functional teams and external partners.
Skilled in troubleshooting, assay optimization, and supporting regulatory submissions (IND, stability, release).
Experience
Analytical Development & QC Scientist – AAV Physical and Chemical Characterization at Franklin Biolabs (Transitioned from UPenn Gene Therapy Program) (2024-10 – Present)
- Lead execution of QC assays including compendial assays, DLS, Mass Photometry, AUC, CE-SDS, SEC-MALS, and SDS-PAGE for AAV-based therapeutics
- Leveraged Mass Photometry for root cause analysis of AAV process deviations
- Authored CE-SDS pre-qualification report to characterize VP ratios and impurities in AAV products
- Authored a white paper comparing Mass Photometry and AUC for AAV capsid content characterization, highlighting relative advantages in throughput, resolution, and regulatory alignment
Analytical Development & QC Scientist – AAV Physical and Chemical Characterization at University of Pennsylvania Gene Therapy Program (2022-06 – 2024-09)
- Developed and pre-qualified CE-SDS and Mass Photometry methods for AAV capsid identity, impurity profiling, and capsid content quantification (Empty/Partial/Full/Overfull) in alignment with ICH guidelines
- Oversaw tech transfer and GLP qualification of Mass Photometry assay at client CDMO
- Characterized AAV, DNA, and LNP samples using DLS, AUC, SEC-MALS, LC-MS, and CE-SDS
- Designed and transferred AEX assay to MS&T to serve as a predictive model for large-scale purification
- Authored SOPs for Mass Photometry, SEC-MALS, CE-SDS, and SDS-PAGE assays
- Delivered technical presentations to stakeholders including project teams, QA, and external collaborators
- Performed QC testing for release, toxicology, and stability studies under GLP
- Consulted on data and sample tracking management systems using Veeva and LIMS
Analytical Development Associate – AAV Chemical and Biochemical Characterization at Spark Therapeutics, Inc. (2021-11 – 2022-06)
- Developed and pre-qualified multiple SEC-MALS methods; successfully transferred to QC for routine use
- Performed method optimization to enhance analytical performance and throughput of SEC-MALS assays
- Conducted routine and non-routine testing on experimental gene therapy drug substances
Research And Development Scientist – Immuno-Diagnostics at Thermo Fisher Scientific (2021-07 – 2021-11)
- Supported product development for LabType diagnostic assays
- Investigated and resolved customer-reported assay discrepancies
- Optimized PCR, primer design, conjugation, hybridization, and data analysis to improve assay robustness
Research Assistant – Fungal Secondary Metabolites/Natural Products at University of Southern California (2018-01 – 2020-08)
- Engineered fungal biosynthetic pathways to investigate enzyme-substrate relationships
- Purified and analyzed novel fungal metabolites using LC-MS, NMR, and semi-synthesis
- Analyzed NGS data to identify unexplored gene clusters associated with secondary metabolite production
Research Assistant – Peptide Chemistry at University of Southern California (2017-08 – 2018-01)
- Synthesized over 20 peptides and cyclotides via solid-phase peptide synthesis for structure-activity studies
- Applied SEC, IEX, and HPLC-MS for purification and characterization
- Explored receptor-ligand interactions using FRET and E. coli-based protein expression systems
Research Assistant – Computational Biochemistry at Fox Chase Cancer Center (2016-06 – 2017-05)
- Developed Python-based tools for large-scale structural analysis of kinase crystal structures
- Used machine learning to classify kinase inhibitor interactions based on structural features
- Conducted docking simulations to guide development of novel kinase inhibitors
Laboratory Technician – Organic Synthesis at Thomas Jefferson University (2016-08 – 2017-05)
Performed various chemical synthesis to support collaborative biological studies
Education
M.S. in Pharmaceutical Science – University of Southern California (2020-08)
B.S. in Pre-Medical Studies (minor in chemistry) – Philadelphia University (2017-05)

